CorMedix Balance Sheet Health
Financial Health criteria checks 6/6
CorMedix has a total shareholder equity of $70.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $82.1M and $11.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$76.03m |
Equity | US$70.14m |
Total liabilities | US$11.92m |
Total assets | US$82.06m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 19KA's short term assets ($79.5M) exceed its short term liabilities ($11.4M).
Long Term Liabilities: 19KA's short term assets ($79.5M) exceed its long term liabilities ($517.0K).
Debt to Equity History and Analysis
Debt Level: 19KA is debt free.
Reducing Debt: 19KA has no debt compared to 5 years ago when its debt to equity ratio was 124.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 19KA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 19KA has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 5.1% each year.